HOOKIPA Pharma Inc.

NasdaqCM:HOOK Stock Report

Market Cap: US$22.8m

HOOKIPA Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:HOOK Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Feb 25SellUS$190FMR LLCCompany100US$1.90
04 Feb 25SellUS$688FMR LLCCompany366US$1.88
30 Jan 25SellUS$4,228Fidelity International LtdCompany2,114US$2.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of HOOK?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders14,9900.124%
Public Companies1,875,94715.6%
Institutions2,711,94822.5%
Hedge Funds3,212,33126.6%
General Public4,239,32335.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 64.67% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
26.7%
Baker Bros. Advisors LP
3,212,331US$6.1m-30.7%0.05%
15.6%
Gilead Sciences, Inc.
1,875,947US$3.5m0%no data
4.74%
EcoR1 Capital, LLC
571,727US$1.1m0%0.04%
4.7%
Artal Group S.A.
566,640US$1.1m0%0.03%
4.14%
Knoll Capital Management
498,625US$942.4k-9.63%0.58%
1.77%
The Vanguard Group, Inc.
213,222US$403.0k0%no data
1.46%
Fidelity International Ltd
175,607US$331.9k0%no data
1.46%
FMR LLC
175,607US$331.9k-48.5%no data
0.88%
Redmile Group, LLC
106,376US$201.1k0%0.01%
0.6%
Geode Capital Management, LLC
72,679US$137.4k2.68%no data
0.5%
Acadian Asset Management LLC
60,660US$114.6k-28.5%no data
0.44%
Ikarian Capital, LLC
53,076US$100.3k0%0.03%
0.4%
Dimensional Fund Advisors LP
48,635US$91.9k0%no data
0.26%
Renaissance Technologies LLC
31,470US$59.5k4.12%no data
0.2%
Royal Bank of Canada, Banking & Securities Investments
23,630US$44.7k9.69%no data
0.14%
State Street Global Advisors, Inc.
16,967US$32.1k-0.01%no data
0.13%
Northern Trust Global Investments
15,661US$29.6k-0.01%no data
0.1%
BlackRock, Inc.
12,250US$23.2k0%no data
0.098%
Boothbay Fund Management, LLC
11,768US$22.2k0%no data
0.095%
PGIM, Inc.
11,400US$21.5k0%no data
0.093%
Citadel Advisors LLC
11,173US$21.1k0%no data
0.089%
Pacific Life Fund Advisors LLC
10,725US$20.3k0%no data
0.062%
Morgan Stanley, Investment Banking and Brokerage Investments
7,441US$14.1k-68.5%no data
0.06%
Joern Aldag
7,195US$13.6k0%no data
0.036%
Reinhard Kandera
4,309US$8.1k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/17 05:59
End of Day Share Price 2025/02/14 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

HOOKIPA Pharma Inc. is covered by 10 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Alec StranahanBofA Global Research
Yu HeH.C. Wainwright & Co.
Swayampakula RamakanthH.C. Wainwright & Co.